Empa PASS on Urinary Tract Malignancies

NCT03464045 · clinicaltrials.gov ↗

COMPLETED

Status

344995

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: empagliflozin
DRUG: DPP-4 inhibitors

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]